nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Thrombocytopenia—Ifosfamide—testicular cancer	0.0019	0.0019	CcSEcCtD
Vancomycin—Anaemia—Cisplatin—testicular cancer	0.00189	0.00189	CcSEcCtD
Vancomycin—Skin disorder—Ifosfamide—testicular cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Phlebitis—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Thrombophlebitis—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Vancomycin—Vomiting—Chlorambucil—testicular cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Vancomycin—Renal impairment—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Vancomycin—Dermatitis bullous—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Fatigue—Dactinomycin—testicular cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Back pain—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Vancomycin—Hypotension—Ifosfamide—testicular cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Pain—Dactinomycin—testicular cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Muscle spasms—Etoposide—testicular cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Urticaria—Bleomycin—testicular cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Body temperature increased—Bleomycin—testicular cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Dizziness—Vinblastine—testicular cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Nausea—Chlorambucil—testicular cancer	0.00174	0.00174	CcSEcCtD
Vancomycin—Anaemia—Etoposide—testicular cancer	0.00174	0.00174	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Dyspnoea—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Vomiting—Vinblastine—testicular cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Vertigo—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Headache—Vinblastine—testicular cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Body temperature increased—Dactinomycin—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Abdominal pain—Dactinomycin—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Fatigue—Ifosfamide—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Anaphylactic shock—Cisplatin—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Hypersensitivity—Bleomycin—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Infection—Cisplatin—testicular cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Constipation—Ifosfamide—testicular cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Pain—Ifosfamide—testicular cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Nervous system disorder—Cisplatin—testicular cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Thrombocytopenia—Cisplatin—testicular cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Blood creatinine increased—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Vancomycin—Tachycardia—Cisplatin—testicular cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Asthenia—Bleomycin—testicular cancer	0.00163	0.00163	CcSEcCtD
Vancomycin—Skin disorder—Cisplatin—testicular cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Pruritus—Bleomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Eosinophilia—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Vancomycin—Nausea—Vinblastine—testicular cancer	0.0016	0.0016	CcSEcCtD
Vancomycin—Hypokalaemia—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Vancomycin—Hypotension—Cisplatin—testicular cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Hypersensitivity—Dactinomycin—testicular cancer	0.00156	0.00156	CcSEcCtD
Vancomycin—Urticaria—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Vancomycin—Abdominal pain—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Body temperature increased—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Anaphylactic shock—Etoposide—testicular cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Infection—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Asthenia—Dactinomycin—testicular cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Vancomycin—Neutropenia—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Vancomycin—Thrombocytopenia—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Tachycardia—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Eosinophilia—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Dyspnoea—Cisplatin—testicular cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Skin disorder—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Vomiting—Bleomycin—testicular cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Infestation NOS—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Infestation—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Hypotension—Etoposide—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Rash—Bleomycin—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Pain—Cisplatin—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Dermatitis—Bleomycin—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Hypersensitivity—Ifosfamide—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Renal failure—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Neutropenia—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Asthenia—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Pruritus—Ifosfamide—testicular cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Dyspnoea—Etoposide—testicular cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Nausea—Bleomycin—testicular cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Infestation—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Infestation NOS—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Vomiting—Dactinomycin—testicular cancer	0.00135	0.00135	CcSEcCtD
Vancomycin—Agranulocytosis—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Vancomycin—Rash—Dactinomycin—testicular cancer	0.00133	0.00133	CcSEcCtD
Vancomycin—Renal failure—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Body temperature increased—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Fatigue—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Pain—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Constipation—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Urinary tract infection—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Dizziness—Ifosfamide—testicular cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Nausea—Dactinomycin—testicular cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Agranulocytosis—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Gastrointestinal pain—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Vomiting—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Hypersensitivity—Cisplatin—testicular cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Bradycardia—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Rash—Ifosfamide—testicular cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Dermatitis—Ifosfamide—testicular cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Erythema multiforme—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Urticaria—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Abdominal pain—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Body temperature increased—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Tinnitus—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Asthenia—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Vancomycin—Oedema peripheral—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Connective tissue disorder—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Chills—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Nausea—Ifosfamide—testicular cancer	0.00115	0.00115	CcSEcCtD
Vancomycin—Erythema multiforme—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Hypersensitivity—Etoposide—testicular cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Tinnitus—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Erythema—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Malnutrition—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Flushing—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Vancomycin—Asthenia—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Vancomycin—Back pain—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Chills—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Pruritus—Etoposide—testicular cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Vomiting—Cisplatin—testicular cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Rash—Cisplatin—testicular cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Dermatitis—Cisplatin—testicular cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Erythema—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Malnutrition—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Anaemia—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Flatulence—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Back pain—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Vancomycin—Dizziness—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Muscle spasms—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Vertigo—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Chills—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Vancomycin—Nausea—Cisplatin—testicular cancer	0.000993	0.000993	CcSEcCtD
Vancomycin—Vomiting—Etoposide—testicular cancer	0.000974	0.000974	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—testicular cancer	0.000974	0.000974	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—testicular cancer	0.000974	0.000974	CcSEcCtD
Vancomycin—Anaemia—Epirubicin—testicular cancer	0.000973	0.000973	CcSEcCtD
Vancomycin—Rash—Etoposide—testicular cancer	0.000966	0.000966	CcSEcCtD
Vancomycin—Dermatitis—Etoposide—testicular cancer	0.000965	0.000965	CcSEcCtD
Vancomycin—Headache—Etoposide—testicular cancer	0.00096	0.00096	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000951	0.000951	CcSEcCtD
Vancomycin—Vertigo—Epirubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—testicular cancer	0.000942	0.000942	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—testicular cancer	0.000936	0.000936	CcSEcCtD
Vancomycin—Palpitations—Epirubicin—testicular cancer	0.00093	0.00093	CcSEcCtD
Vancomycin—Anaphylactic shock—Methotrexate—testicular cancer	0.000918	0.000918	CcSEcCtD
Vancomycin—Infection—Methotrexate—testicular cancer	0.000912	0.000912	CcSEcCtD
Vancomycin—Nausea—Etoposide—testicular cancer	0.00091	0.00091	CcSEcCtD
Vancomycin—Nervous system disorder—Methotrexate—testicular cancer	0.0009	0.0009	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Vancomycin—Thrombocytopenia—Methotrexate—testicular cancer	0.000899	0.000899	CcSEcCtD
Vancomycin—Skin disorder—Methotrexate—testicular cancer	0.000891	0.000891	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00089	0.00089	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—testicular cancer	0.000875	0.000875	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Vancomycin—Anaphylactic shock—Epirubicin—testicular cancer	0.000859	0.000859	CcSEcCtD
Vancomycin—Hypotension—Methotrexate—testicular cancer	0.000858	0.000858	CcSEcCtD
Vancomycin—Infection—Epirubicin—testicular cancer	0.000853	0.000853	CcSEcCtD
Vancomycin—Nervous system disorder—Epirubicin—testicular cancer	0.000842	0.000842	CcSEcCtD
Vancomycin—Thrombocytopenia—Epirubicin—testicular cancer	0.000841	0.000841	CcSEcCtD
Vancomycin—Tachycardia—Epirubicin—testicular cancer	0.000838	0.000838	CcSEcCtD
Vancomycin—Skin disorder—Epirubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Vancomycin—Insomnia—Methotrexate—testicular cancer	0.00083	0.00083	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000823	0.000823	CcSEcCtD
Vancomycin—Dyspnoea—Methotrexate—testicular cancer	0.000818	0.000818	CcSEcCtD
Vancomycin—Hypotension—Epirubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000792	0.000792	CcSEcCtD
Vancomycin—Fatigue—Methotrexate—testicular cancer	0.000791	0.000791	CcSEcCtD
Vancomycin—Infection—Doxorubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Vancomycin—Pain—Methotrexate—testicular cancer	0.000785	0.000785	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Vancomycin—Insomnia—Epirubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—testicular cancer	0.000776	0.000776	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Vancomycin—Dyspnoea—Epirubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Vancomycin—Gastrointestinal pain—Methotrexate—testicular cancer	0.00075	0.00075	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000741	0.000741	CcSEcCtD
Vancomycin—Fatigue—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Vancomycin—Constipation—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Vancomycin—Pain—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Vancomycin—Urticaria—Methotrexate—testicular cancer	0.000729	0.000729	CcSEcCtD
Vancomycin—Abdominal pain—Methotrexate—testicular cancer	0.000725	0.000725	CcSEcCtD
Vancomycin—Body temperature increased—Methotrexate—testicular cancer	0.000725	0.000725	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Vancomycin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000702	0.000702	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Vancomycin—Urticaria—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Vancomycin—Pain—Doxorubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Vancomycin—Abdominal pain—Epirubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Vancomycin—Body temperature increased—Epirubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Vancomycin—Hypersensitivity—Methotrexate—testicular cancer	0.000676	0.000676	CcSEcCtD
Vancomycin—Asthenia—Methotrexate—testicular cancer	0.000658	0.000658	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Vancomycin—Pruritus—Methotrexate—testicular cancer	0.000649	0.000649	CcSEcCtD
Vancomycin—Hypersensitivity—Epirubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Vancomycin—Asthenia—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Vancomycin—Pruritus—Epirubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
Vancomycin—Dizziness—Methotrexate—testicular cancer	0.000607	0.000607	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—testicular cancer	0.000585	0.000585	CcSEcCtD
Vancomycin—Vomiting—Methotrexate—testicular cancer	0.000583	0.000583	CcSEcCtD
Vancomycin—Rash—Methotrexate—testicular cancer	0.000579	0.000579	CcSEcCtD
Vancomycin—Dermatitis—Methotrexate—testicular cancer	0.000578	0.000578	CcSEcCtD
Vancomycin—Headache—Methotrexate—testicular cancer	0.000575	0.000575	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Vancomycin—Dizziness—Epirubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Vancomycin—Vomiting—Epirubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Vancomycin—Nausea—Methotrexate—testicular cancer	0.000545	0.000545	CcSEcCtD
Vancomycin—Rash—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Vancomycin—Dermatitis—Epirubicin—testicular cancer	0.000541	0.000541	CcSEcCtD
Vancomycin—Headache—Epirubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Vancomycin—Nausea—Epirubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Vancomycin—Rash—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Vancomycin—Headache—Doxorubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—testicular cancer	0.000472	0.000472	CcSEcCtD
